Too many choices?

Yep patient choice in the insulin pump space sure is being stifled. Let’s count’em up – Medtronic – Tandem – Insulet are available here in the US – Roche has begun selling the Solo in Europe and we have Onduo – CellNovo – Bigfoot – Lilly -all working on their own way cool whiz bang systems. It seems you can’t swing that poor dead cat without hitting an insulin pump company. Now we will not go into our normal rant about how many of these insulin pump wannabes are paying a heavy price to get their heads bashed in. However, what will say is . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.